MedPath

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Phase 2
Completed
Conditions
Crohn's Disease
Interventions
Drug: PF-00547659 SC injection
Registration Number
NCT01276509
Lead Sponsor
Shire
Brief Summary

Adults with Crohn's disease that is clinically active despite conventional treatment will be eligible for this study. Patients may receive one of three doses of PF-00547659 (experimental drug) or placebo (inactive drug). Disease activity will be measured every two weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
265
Inclusion Criteria
  • Subjects must have failed or are intolerant to anti-TNFs and/or immunosuppressants (AZA, 6-MP, and/or MTX).
  • hsCRP greater than 3mg/L
  • Ulcerations demonstrated by colonoscopy performed during screening or 8 weeks prior to screening
Exclusion Criteria
  • Pregnant or breast feeding
  • Short bowel syndrome due to multiple small bowel resections
  • Presence of a stoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo-SC InjectionPF-00547659 SC injectionPlacebo delivered SC, 3 doses separated by 4 weeks.
Drug Dose level 2-SC injectionPF-00547659 SC injectionDrug dose level 2 delievered SC, 3 doses separated by 4 weeks.
Drug Dose level 1- SC injectionPF-00547659 SC injectionDrug dose level 1 delivered SC, 3 doses separated by 4 weeks.
Drug Dose level 3- SC injectionPF-00547659 SC injectionDrug dose level 3 delivered SC, 3 doses separated by 4 weeks.
Primary Outcome Measures
NameTimeMethod
Percentage of Participants With Crohn's Disease Activity Index (CDAI) 70 Response RateWeek 8 and week 12

Crohn's Disease Activity Index (CDAI) is a number which consists of information collected from a 7-day diary from the participants regarding symptoms. Remission is considered a score of 150 or less. Active disease is considered 200 or greater. A response to therapy is considered a decline in CDAI score of 70-points from baseline. CDAI response rate at week 8 and week 12 was measured between the investigational product group and the placebo group.

Secondary Outcome Measures
NameTimeMethod
Safety and Tolerability of PF-00547659 Dose Levels Versus PlaceboWeek 0-12

Number of participants with adverse events (AEs), withdrawals due to AEs and Serious AEs (SAEs) were reported.

The Pharmacokinetics (PK) of Total PF-00547659 - Time for Cmax (Tmax)Day 1, 14, 28, 42, 56, 70, 84, 112, 140, 168, 196, 224 and 252

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to AUC, CL and half life were estimated using data pooled from both typical and additional PK groups. Tmax is time for Cmax.

Number of Adverse Events (AEs) - PF-00547659 Dose Levels Versus PlaceboWeek 0-12

Number of adverse events (all causalities and treatment related) was reported between the investigational product groups and the placebo group.

Percentage of Participants With a Crohn's Disease Activity Index (CDAI) RemissionWeeks 8 and week 12

Percentage of participants with a CDAI remission (defined as a CDAI reduction to \<150 points).

The Pharmacokinetics (PK) of Total PF-00547659 - Area Under the Concentration Time Profile From Time Zero Extrapolated to Infinite Time (AUCinf)Day 1, 14, 28, 42, 56, 70, 84, 112, 140, 168, 196, 224 and 252

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to area under the concentration-time profile (AUC), clearance (CL) and half life were estimated using data pooled from both typical and additional PK groups. AUCinf is area under the concentration time profile from time zero extrapolated to infinite time.

Crohn's Disease Activity Index (CDAI)-70 Response Rates Over TimeWeek 2, 4, 6, 8, 10 and 12

Percentage of participants with Crohn's Disease Activity Index (CDAI)-70 response were reported.

Crohn's Disease Activity Index (CDAI) -100 Response Rates Over TimerWeek 2, 4, 6, 8, 10 and 12

Percentage of participants with Crohn's Disease Activity Index (CDAI)-100 response were reported.

The Pharmacokinetics (PK) of Total PF-00547659 - Terminal Half Life (Thalf)Day 1, 14, 28, 42, 56, 70, 84, 112, 140, 168, 196, 224 and 252

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to AUC, CL and half life were estimated using data pooled from both typical and additional PK groups. Thalf is terminal half life.

Immunogenicity Assessment of Anti-drug Antibodies (ADAs)Day 1, Week 4, Week 8, Week 12, Week 20, Week 28, Week 36

Confirmed cumulative incidence of anti-drug antibodies development to PF-00547659

The Pharmacokinetics (PK) of Total PF-00547659 - Area Under the Concentration Time Profile From Time Zero to Time Tau (AUCtau)Day 1, 14, and 28

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to AUC, CL and half life were estimated using data pooled from both typical and additional PK groups. AUCtau is area under the concentration time profile from time zero to time tau, the dosing interval, where tau = 672 hours (4 weeks)

The Pharmacokinetics (PK) of Total PF-00547659 - Maximum Observed Concentration (Cmax)Day 1, 14, 28, 42, 56, 70, 84, 112, 140, 168, 196, 224 and 252

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to AUC, CL and half life were estimated using data pooled from both typical and additional PK groups. Cmax is maximum observed concentration.

The Pharmacokinetics (PK) of Total PF-00547659 - Apparent Clearance (CL/F)Day 1, 14, 28, 42, 56, 70, 84, 112, 140, 168, 196, 224 and 252

The Pharmacokinetics (PK) of total PF-00547659 was characterized using a population PK approach. PK parameters including but not limited to AUC, CL and half life were estimated using data pooled from both typical and additional PK groups. CL/F is apparent clearance.

Trial Locations

Locations (137)

Nassau Gastroenterology Associates Office Based Surgery

🇺🇸

Great Neck, New York, United States

Nassau Gastroenterology Associates, P.C.

🇺🇸

Great Neck, New York, United States

North Shore Primary Care, P.C.

🇺🇸

Great Neck, New York, United States

Wits Clinical Research

🇿🇦

Johannesburg, Gauteng, South Africa

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

University of Miami

🇺🇸

Miami, Florida, United States

UCSD Medical Center-Thornton Hospital

🇺🇸

La Jolla, California, United States

Clopton Clinic

🇺🇸

Jonesboro, Arkansas, United States

University of Miami Hospital

🇺🇸

Miami, Florida, United States

Florida Center for Gastroenterology

🇺🇸

Largo, Florida, United States

Heartland Medical Research (Administrative Only)

🇺🇸

Clive, Iowa, United States

Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research

🇺🇸

Chevy Chase, Maryland, United States

Gastroenterology Specialists of Arkansas

🇺🇸

Jonesboro, Arkansas, United States

Centre Hospitalier Universitaire de Liège - Labo Biologie Clinique

🇧🇪

Liege, Belgium

Centre Hospitalier de Mouscron

🇧🇪

Mouscron, Belgium

Connecticut Clinical Research Foundation

🇺🇸

Bristol, Connecticut, United States

Center for Digestive Health

🇺🇸

Troy, Michigan, United States

UMass Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

Surgery Center of Columbia

🇺🇸

Columbia, Missouri, United States

Life Medi-Research And Management

🇺🇸

Brooklyn, New York, United States

Little Rock Diagnostic Clinic, P.A.

🇺🇸

Little Rock, Arkansas, United States

Gastro Diagnostics

🇺🇸

Orange, California, United States

Barnes-Jewish Hospital - Investigational Drug Services

🇺🇸

Saint Louis, Missouri, United States

Sylvester Comprehensive Cancer Center

🇺🇸

Miami, Florida, United States

University of Massachusetts Worcester

🇺🇸

Worcester, Massachusetts, United States

Community Clinical Trials

🇺🇸

Orange, California, United States

Rocky Mountain Gastroenterology Associates

🇺🇸

Thornton, Colorado, United States

Surgical Centers of Michigan

🇺🇸

Troy, Michigan, United States

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Iowa Digestive Disease Center

🇺🇸

Clive, Iowa, United States

Minnesota Gastroenterology, P.A.

🇺🇸

Plymouth, Minnesota, United States

MBAL Sofiamed OOD,Otdelenie po gastroenterologia

🇧🇬

Sofia, Bulgaria

Center for Advanced Medicine

🇺🇸

Saint Louis, Missouri, United States

New York Hospital Queens

🇺🇸

Flushing, New York, United States

University Medical Center Groningen (UMCG)

🇳🇱

Groningen, GR, Netherlands

Consulting Radiology (Xray testing only)

🇺🇸

Plymouth, Minnesota, United States

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

The Offices of Dr. Vincent Armenio, M.D.

🇺🇸

East Providence, Rhode Island, United States

Hopital Beaujon- Essais cliniques

🇫🇷

Clichy Cedex, France

Universitaetsklinikum Schleswig-Holstein

🇩🇪

Kiel, Germany

GI Associates

🇺🇸

Wauwatosa, Wisconsin, United States

Oslo Universitetssykehus

🇳🇴

Oslo, Norway

AKH Wien Universitaetsklinik fuer Innere Medizin III

🇦🇹

Wien, Austria

Bayside Endoscopy Center

🇺🇸

Providence, Rhode Island, United States

Charlottesville Gastroenterology Associates

🇺🇸

Charlottesville, Virginia, United States

Oshawa Clinic

🇨🇦

Oshawa, Ontario, Canada

Hillsborough Campus

🇺🇸

Hillsborough, North Carolina, United States

Pasadena Gastroenterology Associates, P.A. dba Digestive Health Center

🇺🇸

Pasadena, Texas, United States

Pharma Resource

🇺🇸

East Providence, Rhode Island, United States

Charlottesville Medical Research

🇺🇸

Charlottesville, Virginia, United States

Allegiance Research Specialists

🇺🇸

Wauwatosa, Wisconsin, United States

Hopital Charles Nicolle

🇫🇷

Rouen Cedex 1, France

Hopital Rangueil

🇫🇷

Toulouse cedex 09, France

Centrum Medyczne-Szpital Swietej Rodziny Sp. z o.o.

🇵🇱

Lodz, Poland

CHU Amiens Hopital Nord Service d'Hepato-Gastroenterologie

🇫🇷

Amiens Cedex 01, France

Charite - Campus Berlin Mitte Medizinische Klinik

🇩🇪

Berlin, Germany

4-MHAT

🇧🇬

Sofia, Bulgaria

Universitaetsfrauenklinikum Schleswig-Holstein Medizinische Klinik I, Gastroenterologie/Hepatologie

🇩🇪

Luebeck, Germany

Yeungnam University Hospital

🇰🇷

Daegu, Korea, Republic of

National Hospital Organization Hirosaki National Hospital

🇯🇵

Hirosaki, Aomori, Japan

Jikei University Hospital

🇯🇵

Minato-ku, Tokyo, Japan

Universitaetsklinikum Regensburg

🇩🇪

Regensburg, Germany

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Chiba University Hospital

🇯🇵

Chiba, Japan

Hopital de l'Archet 2 - CHU de Nice

🇫🇷

NICE Cedex 3, France

Robert-Bosch-Krankenhaus

🇩🇪

Stuttgart, Germany

Hospital General Universitario Gregorio Maranon

🇪🇸

Madrid, Spain

Military Medical Academy

🇷🇸

Belgrade, Serbia

Clinical Hospital Centre Bezanijska Kosa

🇷🇸

Belgrade, Serbia

Gastroentero-Hepatologicke centrum THALION, LAMA MEDICAL CARE s.r.o.

🇸🇰

Bratislava, Slovakia

Hospital Universitari Bellvitge

🇪🇸

Barcelona, Spain

Minneapolis Heart Institute, West Health Campus

🇺🇸

Minneapolis, Minnesota, United States

Noran Neurology Clinic

🇺🇸

Minneapolis, Minnesota, United States

Nashville Medical Research Institute

🇺🇸

Nashville, Tennessee, United States

University of Utah HSC

🇺🇸

Salt Lake City, Utah, United States

Hopital Nord

🇫🇷

St Priest En Jarez, France

Hospital Universitario de La Princesa

🇪🇸

Madrid, Spain

East side Endoscopy, LLC (for colonscopy testing only)

🇺🇸

New York, New York, United States

Lenox Hill Endoscopy Center

🇺🇸

New York, New York, United States

University of Miami Hospital and Clinic

🇺🇸

Miami, Florida, United States

Mayo Clinic Jacksonville

🇺🇸

Jacksonville, Florida, United States

Audrain Medical Center

🇺🇸

Mexico, Missouri, United States

Center for Digestive and Liver Diseases, Inc.

🇺🇸

Mexico, Missouri, United States

Premier Medical Group of the Hudson Valley

🇺🇸

Poughkeepsie, New York, United States

Albany Medical College

🇺🇸

Albany, New York, United States

Long Island Clinical Research Associates, LLP

🇺🇸

Great Neck, New York, United States

Beth Israel Medical Center - Phillip Ambulatory Care Center

🇺🇸

New York, New York, United States

UZ Gasthuisberg

🇧🇪

Leuven, Belgium

Centre Hospitalier Universitaire de Liege

🇧🇪

Liege, Belgium

Vancouver Coastal Health - Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

Vancouver Coastal Health - Vancouver Hospital

🇨🇦

Vancouver, British Columbia, Canada

Toronto Digestive Disease Associates Inc.

🇨🇦

Vaughan, Ontario, Canada

Hopital Cochin-Essais Cliniques

🇫🇷

Paris, France

Hopital Saint-Andre

🇫🇷

Bordeaux cedex, France

Gastroenterologische Gemeinschaftspraxis Minden

🇩🇪

Minden, Germany

Krankenhaus Martha-Maria Halle-Doelau gGmbH

🇩🇪

Halle, Germany

Universitaetklinikum Ulm

🇩🇪

Ulm, Germany

Keio University Hospital

🇯🇵

Shinjuku-ku, Tokyo, Japan

National Hospital Organization Takasaki General Medical Center

🇯🇵

Takasaki, Gunma, Japan

Aichi Medical University Hospital

🇯🇵

Aichi, Japan

Yokohama City University Medical Center

🇯🇵

Kanagawa, Japan

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Yonsei University College of Medicine, Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Academic Medical Center

🇳🇱

Amsterdam, NH, Netherlands

Maastricht University Medical Center

🇳🇱

Maastricht, Netherlands

Asker And Baerum Hospital

🇳🇴

Gjettum, Norway

Lexmedica

🇵🇱

Wroclaw, Poland

Lovisenberg Diakonale Sykehus

🇳🇴

Oslo, Norway

Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych w Warszawie

🇵🇱

Warszawa, Poland

Clinical Hospital Center Zemun

🇷🇸

Zemun, Serbia

Clinical Center Nis Clinic for Gastroenterology and Hepatology

🇷🇸

Nis, Serbia

Gastroenterologicke a hepatologicke centrum Nitra, KM Management spol. s r.o.

🇸🇰

Nitra, Slovakia

Medak s.r.o.

🇸🇰

Bratislava, Slovakia

Synergy group, a.s.

🇸🇰

Nove Mesto Nad Vahom, Slovakia

Parklands Medical Centre

🇿🇦

Durban, Kwa-zulu - Natal, South Africa

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

Hospital Puerta de Hierro Majadahonda

🇪🇸

Majadahonda, Madrid, Spain

Corporacio Sanitaria Parc Tauli de Sabadell

🇪🇸

Sabadell, Spain

Szpital Uniwersytecki nr 2 im dr. Jana Bizieta w Bydgoszczy Centrum Endoskopii Zabiegowej

🇵🇱

Bydgoszcz, Poland

Kingsbury Hospital

🇿🇦

Cape Town, Western CAPE, South Africa

Cirtus Ambulartory Surgery Center

🇺🇸

Orlando, Florida, United States

Internal Medicine Specialists

🇺🇸

Orlando, Florida, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

CTRC Hospital - UNC Memorial Hospital

🇺🇸

Chapel Hill, North Carolina, United States

North Carolina Memorial Hospital Endoscopy Center

🇺🇸

Chapel Hill, North Carolina, United States

UNC Hospitals Department of Pharmacy

🇺🇸

Chapel Hill, North Carolina, United States

UNC Hospitals Endoscopy

🇺🇸

Chapel Hill, North Carolina, United States

Shands Endoscopy Center

🇺🇸

Gainesville, Florida, United States

Shands Hospital at the University of Florida

🇺🇸

Gainesville, Florida, United States

Shands Medical Plaza

🇺🇸

Gainesville, Florida, United States

Clinical Research of the Rockies

🇺🇸

Lafayette, Colorado, United States

BioMark Research Inc.

🇺🇸

Whittier, California, United States

Iowa Endoscopy Center (Colonoscopy Only)

🇺🇸

Clive, Iowa, United States

Inland Gastroenterology Medical Associates, Inc.

🇺🇸

Redlands, California, United States

© Copyright 2025. All Rights Reserved by MedPath